Remix Therapeutics is a Biotech company based in Watertown, Massachusetts. It has raised $211M in total funding. Latest round: Growth.
Remix Therapeutics is a Biotech company based in Watertown, Massachusetts. Remix Therapeutics has raised $211M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in January 2024. The round record for Remix Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Atlas Venture, The Column Group, Foresite Capital, Surveyor Capital. 4 distinct backers are named across the disclosed rounds.
Round data for Remix Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Watertown and backer lists below.
1 disclosed round on record, including 1 reported through SEC Form D filings.
SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.
Company funding database · Investor directory · Founder database · Mega-rounds 2026